Home

   

Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations: CLEAR-AD (U19 AG074879)

Mayo Clinic Florida and Indiana University School of Medicine  are leading a $41 million NIH program over 5 years towards personalized medicine in Alzheimer’s disease (AD) and related disorders.

CLEAR-AD Collaborating Organizations

Clear-AD logo created with BioRender.org